Font Size:
The European Union sent the first batches of the experimental drug Favipiravir to France, Spain and the Netherlands to counter the hantavirus. This came after the Japanese company Fujifilm donated 1,400 tablets, in the absence of an officially approved treatment for the virus.
The European Union has announced the distribution of the first shipment of the experimental anti-Hantavirus drug to three member states, as part of urgent efforts to contain an outbreak of the disease that threatens European public health. France, Spain and the Netherlands each received rations of 1,400 tablets of Favipiravir, after a generous donation from Japanese pharmaceutical company Fujifilm, according to the European Commission. Favipiravir An advanced position among the currently available treatment options, especially in the absence of any officially approved treatment or vaccine to fight the hantavirus so far. The European Medicines Agency explained that the drug is the most appropriate option for urgent use, both in clinical trials and through “compassionate use” protocols that make unlicensed drugs available to patients in critical situations. The Commission affirmed respect for the sovereignty of the decision National, as each country will reserve the right to determine the mechanism of use of the drug according to its own medical and epidemiological assessment. Hajja Habib, EU Commissioner for Preparedness and Crisis Management, praised the fruitful international cooperation with the Japanese authorities, stressing that solidarity and rapid response are pivotal factors in saving lives.
Source: Al-Wehda Al-Arabia News Portal
